Sort
17,828 grants matching “crispr”
Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
$46,752Bianca Diaz · Weill Medical Coll Of Cornell Univ · F31 · FY2022 · CA
Neuronal and homeostatic regulation of sleep and wake by corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus
$46,752Alyssa N Wiest · University Of Pennsylvania · F31 · FY2022 · HL
Implicating novel microglial mechanisms of late-onset Alzheimer's disease with variant-to-gene mapping methods
$46,752Elizabeth Anne Burton · University Of Pennsylvania · F31 · FY2022 · AG
Dynamic regulation of synaptic Ca2+ channel organization
$46,752Audrey Taylor Medeiros · Brown University · F31 · FY2022 · NS
Metabolic Impact of Tryptophan Synthase Inhibition in Mycobacterium tuberculosis and Implications for Rational Combination Therapy
$46,752Kyle Planck · Weill Medical Coll Of Cornell Univ · F31 · FY2022 · AI
Defining the role of the nuclear lamina in the mechanical regulation of lung fibrosis
$46,752Emma Carley · Yale University · F31 · FY2022 · HL
A Novel Genome-Wide Screen to Identify and Characterize Regulators of ALS Disease Modifier Gene Ataxin-2
$46,752Garam Kim · Stanford University · F31 · FY2022 · NS
Investigating the Interplay between Senescent Cells and T Cells in Cancer
$46,752Caroline Broderick · Weill Medical Coll Of Cornell Univ · F31 · FY2022 · CA
Mechanisms of secretion and uptake of small extracellular vesicles (sEVs) in non-small cell lung cancer (NSCLC)
$46,752Zulaida Marie Soto Vargas · Purdue University · F31 · FY2022 · CA
The Role of dNp63 in Maladaptive Regeneration and Repair Following Severe Pulmonary Injury
$46,752Aaron Weiner · University Of Pennsylvania · F31 · FY2022 · HL
Dynamics of viral host range evolution
$46,734Graham F. Hatfull · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · GM
Decoding Alzheimer's disease-related enhancers in microglia
$46,730Bethany Rose Fixsen · University Of California, San Diego · F30 · FY2021 · AG
Identifying Metabolic Vulnerabilities in Pancreatic Cancer
$46,516Douglas Biancur · New York University School Of Medicine · F99 · FY2019 · CA
Tumor Intrinsic Regulation of Immune Evasion Pathways in Melanoma
$46,516Sheera Rosenbaum · Thomas Jefferson University · F99 · FY2019 · CA
The Role of Limch1 Alternative Splicing in Skeletal Muscle Function
$46,377Matthew Penna · Baylor College Of Medicine · F31 · FY2021 · AR
Characterization of tumor-specific human endogenous retroviruses in clear cell Renal Cell Carcinoma
$46,368Sophia Kogut · Fred Hutchinson Cancer Center · F31 · FY2025 · CA
Investigating the role of NRF2 in promoting radioresistance in oral squamous cell carcinoma.
$46,320Ryan Mary Murphy · Univ Of North Carolina Chapel Hill · F31 · FY2020 · DE
CRK regulation of ribosome biogenesis and craniofacial development
$46,320Mason McCool · Yale University · F31 · FY2020 · DE
Genome-scale CRISPR activation screening to identify lung-specific metastatic pathways
$46,300Richard Ebright · Harvard Medical School · F30 · FY2020 · CA
The role of GCN2 in human induced pluripotent stem cell maintenance, differentiation and endothelial cell function
$46,272Phoenix Toboz · University Of Illinois At Chicago · F31 · FY2025 · HL
Investigating the Role of Neurotensin on Valence Assignment During Associative Learning in the Basolateral Amygdala
$46,272Jacob Michael Olson · Massachusetts Institute Of Technology · F32 · FY2018 · MH
Norepinephrine and dopamine dynamics during conditioned place preference and aversion in dorsal hippocampus
$46,260Avi Kefir Matarasso · University Of Washington · F31 · FY2022 · DA
Investigating the role of THC in mediating pain signaling in the BLA
$46,249Kaylin Ellioff · University Of Washington · F31 · FY2025 · DA
The role of the extracellular matrix in establishing Schwann cell polarity
$46,175Monique Lillis · University Of California, San Francisco · F31 · FY2025 · NS
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
$46,094Alexandra Munch · Icahn School Of Medicine At Mount Sinai · F31 · FY2023 · AG